Living with chronic skin conditions like psoriasis or atopic dermatitis (AD) often means navigating a maze of treatments—from topical creams to oral medications—with varying degrees of success. For many, the search for a safe, targeted, and effective option ends with 308-nm excimer light therapy. This advanced phototherapy has emerged as a game-changer in dermatological care, backed by research showing it addresses the root causes of multiple skin conditions while minimizing side effects. Here’s a deep dive into its science, applications, and why it’s gaining traction among patients and clinicians alike.

What Is 308-nm Excimer Light Therapy?

308-nm excimer light is a specialized form of phototherapy that delivers focused, high-intensity ultraviolet (UV) light to affected skin areas. Unlike broad-spectrum UV treatments that expose large swathes of healthy skin, this therapy targets lesions with precision—making it ideal for localized conditions (Morita, A. (2018). Current developments in phototherapy for psoriasis. Journal of Dermatology, 45(3), 287-292. https://pubmed.ncbi.nlm.nih.gov/29369396/). Its mechanism relies on two key actions: inducing apoptosis (programmed cell death) in harmful immune cells and suppressing overactive immune responses, which are core drivers of inflammatory skin diseases.

Key Applications: From Psoriasis to Atopic Dermatitis

1. Psoriasis: Targeting Pathogenic T Cells

Psoriasis is driven by an overactive immune system, where pathogenic T cells trigger abnormal skin cell growth and inflammation. 308-nm excimer light directly addresses this by depleting these harmful T cells through apoptosis while boosting levels of regulatory T cells—immune cells that calm inflammation (Morita, A. (2018). Current developments in phototherapy for psoriasis. Journal of Dermatology, 45(3), 287-292. https://pubmed.ncbi.nlm.nih.gov/29369396/). This dual action not only reduces existing plaques but also helps prevent future flares.

What sets it apart from other psoriasis treatments? Its precision. By focusing only on affected areas, it avoids the widespread UV exposure associated with traditional phototherapies, lowering the risk of long-term side effects like skin aging or cancer. It’s also effective for refractory cases—patients who haven’t responded to other treatments like narrowband UV-B (NB-UVB) or topical medications.

2. Atopic Dermatitis (AD): Repairing Skin Barriers & Calming Inflammation

AD, a chronic inflammatory condition characterized by dryness, itching, and impaired skin barriers, also benefits significantly from 308-nm excimer therapy. Research across age groups—from children to adults—confirms its efficacy:

• In a clinical trial of adults and children with localized AD, 66.7% achieved complete remission after 6–12 weekly treatments, with 16.7% experiencing partial relief (Nisticò, S. P., et al. (2008). Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. Photomed Laser Surg, 26(1), 14-18. https://pubmed.ncbi.nlm.nih.gov/18248156/).
• For Korean adults with moderate localized AD, twice-weekly treatments for 4 weeks significantly improved AD severity, reduced transepidermal water loss (a marker of skin barrier damage), and increased skin hydration (Park, B. G., et al. (2023). Preliminary Clinical Study of the Effects and Safety of 308-nm Excimer Light Treatment in Patients with Atopic Dermatitis. Ann Dermatol, 35(6), 417-423. https://pubmed.ncbi.nlm.nih.gov/38086355/).

Animal studies further validate its impact: 308-nm excimer laser reduced AD-like lesions in mice by lowering IgE levels (a key player in allergic inflammation) and Th2 cytokines, while repairing damaged skin barriers (Oh, C. T., et al. (2016). Effect of a 308-nm excimer laser on atopic dermatitis-like skin lesions in NC/Nga mice. Lasers Surg Med, 48(6), 629-637. https://pubmed.ncbi.nlm.nih.gov/27075746/).

3. Cutaneous Sensory Disorders

Beyond psoriasis and AD, 308-nm excimer light is effective for cutaneous sensory disorders—conditions causing abnormal sensations like tingling, burning, or itching (Fonda-Pascual, P., et al. (2021). Effectiveness of 308-nm excimer lamp in the treatment of notalgia paresthetica. J Eur Acad Dermatol Venereol, 35(2), e111-e113. https://pubmed.ncbi.nlm.nih.gov/33043494/). This expands its utility for patients with hard-to-treat symptoms that don’t respond to conventional therapies.

How It Fits Into Comprehensive Skin Care

According to clinical guidelines, 308-nm excimer therapy works best as part of a layered treatment approach (Orfali, R. L., et al. (2023). Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique. An Bras Dermatol, 98(6), 814-836. https://pmc.ncbi.nlm.nih.gov/articles/PMC10589461/):

• Mild cases: Start with topical treatments (e.g., corticosteroids, calcineurin inhibitors) and daily moisturization.
• Moderate-to-severe or refractory cases: Add 308-nm excimer therapy, other phototherapies (NB-UVB, UVA1), traditional systemic drugs (e.g., cyclosporine, methotrexate), or targeted therapies (e.g., dupilumab, JAK inhibitors).

It’s particularly valuable for patients who can’t tolerate systemic medications (which may require ongoing lab monitoring for kidney or liver issues) or prefer a non-pharmaceutical option.

Safety & Tolerability: A Low-Risk Choice

One of the biggest advantages of 308-nm excimer therapy is its excellent safety profile. Studies report no severe adverse effects, with only mild, temporary reactions like redness or slight stinging (Nisticò, S. P., et al. (2008). Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. Photomed Laser Surg, 26(1), 14-18. https://pubmed.ncbi.nlm.nih.gov/18248156/). Unlike long-term systemic treatments, it doesn’t require routine blood work or organ function monitoring.

A note of caution: Patients on immune suppressants should avoid combining them with phototherapy due to increased skin cancer risk (Orfali, R. L., et al. (2023). Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique. An Bras Dermatol, 98(6), 814-836. https://pmc.ncbi.nlm.nih.gov/articles/PMC10589461/). As with any treatment, consult a dermatologist to assess eligibility.

Is 308-nm Excimer Therapy Right for You?

Consider this treatment if you:

• Have localized or moderate-to-severe psoriasis, AD, or cutaneous sensory disorders.
• Haven’t responded to topical medications or other phototherapies.
• Want a non-invasive, low-side-effect option.
• Prefer targeted treatment that spares healthy skin.

Talk to your dermatologist about whether your condition, medical history, and treatment goals align with 308-nm excimer therapy.

Final Thoughts

308-nm excimer light therapy represents a significant advancement in treating chronic inflammatory skin conditions. Its precision, dual mechanism of action (apoptosis and immune suppression), and excellent safety profile make it a versatile choice for patients across age groups. Backed by rigorous research—from psoriasis to AD to sensory disorders—it offers hope for long-term symptom control and improved quality of life.

As dermatological care continues to evolve, 308-nm excimer therapy stands out as a patient-centric option that balances efficacy and safety. Whether you’re struggling with persistent plaques, itchy rashes, or abnormal skin sensations, this evidence-based treatment may be the solution you’ve been searching for.

References

• Fonda-Pascual, P., et al. (2021). Effectiveness of 308-nm excimer lamp in the treatment of notalgia paresthetica. J Eur Acad Dermatol Venereol, 35(2), e111-e113. https://pubmed.ncbi.nlm.nih.gov/33043494/
• Morita, A. (2018). Current developments in phototherapy for psoriasis. Journal of Dermatology, 45(3), 287-292. https://pubmed.ncbi.nlm.nih.gov/29369396/
• Nisticò, S. P., et al. (2008). Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. Photomed Laser Surg, 26(1), 14-18. https://pubmed.ncbi.nlm.nih.gov/18248156/
• Oh, C. T., et al. (2016). Effect of a 308-nm excimer laser on atopic dermatitis-like skin lesions in NC/Nga mice. Lasers Surg Med, 48(6), 629-637. https://pubmed.ncbi.nlm.nih.gov/27075746/
• Orfali, R. L., et al. (2023). Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique. An Bras Dermatol, 98(6), 814-836. https://pmc.ncbi.nlm.nih.gov/articles/PMC10589461/
• Park, B. G., et al. (2023). Preliminary Clinical Study of the Effects and Safety of 308-nm Excimer Light Treatment in Patients with Atopic Dermatitis. Ann Dermatol, 35(6), 417-423. https://pubmed.ncbi.nlm.nih.gov/38086355/